The company’s turnover has tripled in the past 10 years.
2025 was a good year for the company in terms of profitability, too, as profit neared RON410 million.
Terapia has invested over EUR50 million in the past five years.
The main growth directions were the acquisition of Uractiv brand from Fiterman Iasi portfolio, but also new product launches and the retooling of Cluj-Napoca platform production lines.
(English version by Catalina Apostoiu)